RemeGen Co. Ltd. Class A

As of December 31, 2025, RemeGen Co. Ltd. Class A carries a market capitalization of 43.85B, placing it among publicly traded companies globally. Its enterprise value stands at 43.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

RemeGen Co. Ltd. Class A's next confirmed earnings release is scheduled for October 29, 2026.

As of December 31, 2025, RemeGen Co. Ltd. Class A has 563.71M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, RemeGen Co. Ltd. Class A maintains a current ratio of 1.43, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, RemeGen Co. Ltd. Class A's stock has gained approximately 1.79% over the past 52 weeks. The 50-day moving average sits at 118.46, while the 200-day moving average is 115.88.

As of December 31, 2025, RemeGen Co. Ltd. Class A holds 2.37B in cash and equivalents against 2.20B in total debt, resulting in a net debt position of 1.00B. Total book value stands at 3.61B, with working capital of 1.19B providing operational flexibility.